Concepedia

Sridaran Natesan

SN

Statistics

Publications

19

Citations

5.5K

H-Index

17

Active since

1992

Affiliations

Sanofi (United States)(Current)

Harvard University

Howard Hughes Medical Institute

University of Rochester Medical Center

Ariadne Diagnostics (United States)

Sridaran Natesan is an author at Sanofi (United States) specializing in life sciences, molecular biology, and gene expression.

Publications per year

1992–2021

19

Publications

19

Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells

José M. Polo, Susanna Liu, María E. Figueroa et al. · Nature Biotechnology · 2010 · 1.2K citations · Full text

, , +17

A Molecular Roadmap of Reprogramming Somatic Cells into iPS Cells

José M. Polo, Endre Anderssen, Ryan Walsh et al. · Cell · 2012 · 863 citations · Full text

, , +15

Aberrant silencing of imprinted genes on chromosome 12qF1 in mouse induced pluripotent stem cells

Matthias Stadtfeld, Effie Apostolou, Hidenori Akutsu et al. · Nature · 2010 · 769 citations · Full text

, , +17

Distinct roles of Akt1 and Akt2 in regulating cell migration and epithelial–mesenchymal transition

Hanna Y. Irie, Rachel V. Pearline, Dorre A. Grueneberg et al. · The Journal of Cell Biology · 2005 · 590 citations · Full text

, , +17

A humanized system for pharmacologic control of gene expression

Victor M. Rivera, Tim Clackson, Sridaran Natesan et al. · Nature Medicine · 1996 · 544 citations

, , +9

1–5 of 19